文献速递药物相互作用药物不良反应与药物警戒

HIV感染者减重药物治疗的安全性与疗效及与抗逆转录病毒治疗的潜在药物相互作用

Safety and Efficacy of Weight-Loss Pharmacotherapy in Persons Living with HIV: A Review of the Literature and Potential Drug-Drug Interactions with Antiretroviral Therapy.
PubMed 文献 · Pharmacotherapy · 2019-11-03

本文综述HIV感染者中减重药物治疗的有效性及与抗逆转录病毒治疗的潜在相互作用。HIV感染者常未被纳入减重药物临床试验,但疗效可能相似;奥利司他与HIV病毒反弹相关,临床医生应警惕某些减重药物与抗逆转录病毒联用时可能丧失病毒学控制。

要点

  • HIV感染者常被排除在减重药物试验外,但疗效可能接近一般人群。
  • 奥利司他与HIV病毒反弹相关,有多例病例报告。
  • 某些减重药与抗逆转录病毒联用可能丧失病毒学控制。

核心结论

  • HIV感染者减重药物治疗疗效可能相似于一般人群,但需警惕与抗逆转录病毒治疗的药物相互作用。
  • 奥利司他与HIV病毒反弹相关,临床医生应警惕某些减重药物与抗逆转录病毒联用时可能丧失病毒学控制。

研究设计与样本

  • 文献综述,检索范围未在摘要中报告。

主要发现

  • HIV感染者常未被报告或纳入减重药物临床试验。
  • 减重药物治疗疗效可能相似于一般人群。
  • 抗肥胖药物与抗逆转录病毒治疗间存在若干已报告或理论上的药物相互作用。
  • 奥利司他在美国为非处方减重药,数例病例报告将其与HIV病毒反弹相关联。

临床怎么用

  • 临床医生应知晓某些减重药物与抗逆转录病毒联用时可能导致HIV病毒学控制丧失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prevalence of obesity among persons living with human immunodeficiency virus (HIV) has increased significantly and may be linked to the use of antiretroviral therapy. Although weight-loss medications approved by the U.S. Food and Drug Administration are recommended as an adjunct to diet and exercise to treat obesity in the general population, little is known about the safety and efficacy of these drugs specifically in persons living with HIV. We review the available evidence regarding the effective use of weight-loss pharmacotherapy in persons living with HIV and its potential to interact with antiretroviral therapy. Persons living with HIV are frequently not reported or included in clinical trials for weight-loss medications; however, treatment efficacy is likely similar to the general population. Several important reported or theoretical drug-drug interactions exist between antiobesity pharmacotherapy and antiretroviral therapy. Orlistat is a weight-loss drug available in the United States without a prescription and was linked to HIV viral rebound in several case reports. Clinicians should be aware of the potential for loss of HIV viremia control when certain weight-loss pharmacotherapies are used in combination with antiretrovirals.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Cope RJ, Fischetti BS, Kavanagh RK, et al. Safety and Efficacy of Weight-Loss Pharmacotherapy in Persons Living with HIV: A Review of the Literature and Potential Drug-Drug Interactions with Antiretroviral Therapy. Pharmacotherapy. 2019. PMID: 31602703. doi:10.1002/phar.2342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。